Aptose Biosciences Inc. secured $4.43 million in funding through a registered direct offering for working capital and general corporate use.
RECENTLY ACQUIREDJun 03, 2024
Amount Raised
$4.43 Million
Round Type
Seed
San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearch
Investors
H.C. Wainwright & Co.
Description
Aptose Biosciences Inc. has completed a registered direct offering, raising approximately $4.43 million by selling common shares at $1.15 each, as well as issuing series A and B warrants. The funding is intended for working capital and general corporate use.
Company Information
Company
Aptose Biosciences
Location
12770 High Bluff Dr
San Diego, California, United States
About
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies.
Fundz sees it the moment Aptose Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearch